About the Authors
- Elton Rexhepaj
-
Affiliation Department of Genetics and Pathology and Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
- Margrét Agnarsdóttir
-
Affiliation Department of Genetics and Pathology and Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
- Julia Bergman
-
Affiliation Department of Genetics and Pathology and Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
- Per-Henrik Edqvist
-
Affiliation Department of Genetics and Pathology and Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
- Michael Bergqvist
-
Affiliation Section of Oncology, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
- Mathias Uhlén
-
Affiliation Science for Life Laboratory, KTH – Royal Institute of Technology, Stockholm, Sweden
- William M. Gallagher
-
Affiliations UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, Dublin, Ireland, OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin, Ireland
- Emma Lundberg
-
Affiliation Science for Life Laboratory, KTH – Royal Institute of Technology, Stockholm, Sweden
- Fredrik Ponten
-
* E-mail: fredrik.ponten@igp.uu.se
Affiliation Department of Genetics and Pathology and Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
Competing Interests
Prof. William Gallagher is co-founder and Chief Scientific Officer within OncoMark Limited. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. The other authors have no financial or other interests with regard to the pre-submitted abstract that might be construed as conflict of interest.
Author Contributions
Conceived and designed the experiments: ER FP MA. Performed the experiments: JB PHE. Analyzed the data: ER FP. Contributed reagents/materials/analysis tools: EL MU MB WG. Wrote the paper: ER FP.